What is Integra LifeSciences's specialty surgery — SG&A?

Integra LifeSciences (IART) reported specialty surgery — SG&A of $77.68M in Q1 2026.

What does specialty surgery — SG&A mean?

This represents the operating expenses incurred to support the sales, marketing, and general management functions of the Specialty Surgery segment. It is a critical measure of the operational overhead required to maintain and scale the segment's market presence.

Integra LifeSciences IART Specialty Surgery — SG&A

Other segment segments

Tissue Reconstruction

$43.53M—

Similar metrics at other companies

AMRXSpecialty — SG&A

$34.69M+12.0%

AMRXSpecialty — Selling General And Administrative Expense

$34.69M+12.0%

LKQSpecialty — Selling, general and administrative expenses

$84M+10.5%

GTLSSpecialty Products — Selling, general and administrative expenses

$32.9M+8.2%

RPMSpecialty Products Group — Selling General And Administrative Expense

$54.4M+1.4%

TRSSpecialty Products — Selling, General and Administrative Expense

$1.37M-45.6%

Other financials

Income statement

See full

Revenue$391.9M+2.4%

Gross profit$217.0M+11.6%

Operating income$11.5M+174%

Net income-$4.6M+81.7%

EPS (diluted)-$0.06+81.8%

Balance sheet

See full

Cash & equivalents$236.8M-1.0%

Total debt$2.0B+3.2%

Total equity$1.0B-31.6%

Total assets$3.6B-11.7%

Cash flow

See full

Operating cash flow$9.8M+187%

CapEx$14.8M-48.7%

Free cash flow-$5.0M+87.4%

Valuation

See full

Market cap$1.38B-56.8%

Enterprise value$3.12B-26.7%

P/S0.8×-1.1×

Profitability

See full

Gross margin51.9%-1.6pp

Operating margin-29.8%-30.3pp

Net margin-30.1%—

FCF margin3.8%-6.3pp

Returns & leverage

See full

Return on equity-38.6%—

Debt / equity1.9×+0.6×

Current ratio3.4×+2.2×

Where this comes from

Reported directly by Integra LifeSciences in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integra LifeSciences's specialty surgery — sg&a.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Integra LifeSciences's specialty surgery — SG&A?: Integra LifeSciences (IART) reported specialty surgery — SG&A of $77.68M in Q1 2026.
What does specialty surgery — SG&A mean?: This represents the operating expenses incurred to support the sales, marketing, and general management functions of the Specialty Surgery segment. It is a critical measure of the operational overhead required to maintain and scale the segment's market presence.